As more and more Canadians suffering from Multiple Sclerosis travel to other countries to receive the controversial liberation treatment, the results won’t always be positive.
Kate Carnegie explains.
[projekktor src=’https://488b0f6bbd6e1f02d285-a9990803a5649dd3960d912508d8bce9.ssl.cf2.rackcdn.com/2010-1119-014.mp4′]